Schott Pharma with SDAX role, consensus and sector peers guide the stock

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 20:07.

Schott Pharma (DE000A3ENQ51) sits in the SDAX as a German healthcare supplier with a focus on pharma primary packaging and drug delivery systems. The stock trades in Frankfurt alongside sector names such as Sartorius, which also targets biopharma customers on Xetra and regional venues.

Analyst interest and SDAX context

On Finanzen100, Schott Pharma is classified in the medical equipment space, with the SDAX performance index highlighted as the benchmark for the shares. A May analyst roundup on the same portal reports that experts largely recommended the stock as a Buy during that month, signaling constructive sentiment from the research community.

The SDAX itself has recently shown mixed performance, with daily commentaries describing weaker and stronger sessions in Frankfurt across mid-June. These index moves frame Schott Pharma shares in a volatile small and mid-cap environment, where index-level flows can influence individual constituents.

Peers and sector performance

Within German-listed healthcare and lab-supply names, Sartorius preference shares advanced markedly on the Stuttgart exchange on 25 June, gaining around 5 percent to trade above 231 euros in intraday dealings. That performance underlines renewed risk appetite in selected life-science tools stocks, a segment relevant for investors comparing Schott Pharma with peers on valuation and growth.

More broadly, chemicals and specialty materials groups such as Schneider Electric in France also show steady trading activity on European venues, with the share price in Stuttgart quoted around 281 euros on the same day. These cross-sector reference points help investors position Schott Pharma within a wider universe of industrial and healthcare suppliers.

What the company sells

Schott Pharma generates revenue with glass and polymer systems for injectable drugs, including prefillable syringes, vials and cartridges for vaccines and biologics. In June, the group highlighted an expansion of vial production in Lebanon, Pennsylvania, targeting rising demand from U.S. pharmaceutical customers.

Where the stock trades today

Schott Pharma shares (DE000A3ENQ51) trade on Xetra in euros; recent price data on Finanzen100 show the stock quoted within the SDAX segment, with the listing linked to the Frankfurt exchange. The latest available snapshot also places the company in the medical equipment category for sector comparisons.

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities.